Regulatory issues and generic names

Alison Azulay
Additional contact information
Alison Azulay: Markforce Associates

Chapter Chapter 13 in Brand Medicine, 2001, pp 197-210 from Palgrave Macmillan

Abstract: Abstract At a time when thousands of trade mark applications and registrations1 for pharmaceuticals populate the world’s trade mark registers, it is becoming increasingly difficult to create, clear and protect pharmaceutical marks on a global basis. Here we will explore the regulatory issues and legal aspects which impact on the creation of pharmaceutical brands as well as the criteria for trade mark searching and protection for pharmaceutical brands. We will then turn our attention to ways of maintaining the brand well after registration and the use of trade mark notices and symbols. We will also touch upon domain names.

Keywords: Member State; Medicinal Product; Trade Mark; Marketing Authorization; Mutual Recognition (search for similar items in EconPapers)
Date: 2001
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-52251-0_14

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230522510

DOI: 10.1057/9780230522510_14

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().